[Effect of over expression of HPV18 E2 protein on apoptosis and secretion of macrophages]

Jun Peng1, Cui-ming Zhu, Min-jun Yu

  • 1Institute of Pathogenic Biology, University of South China, Hengyang 421001, China. junpeng7758@yahoo.com.cn

Abstract

Insights

Overexpressing the HPV18 E2 gene or its N-terminal domain (TAD) in macrophages boosts cytokine secretion and apoptosis. This suggests a role for the E2 gene in uterine cervix cancer progression.

Area of Science:

  • Molecular biology
  • Immunology
  • Oncology

Context:

  • Human papillomavirus type 18 (HPV18) E2 protein plays a role in viral replication and pathogenesis.
  • Understanding the interaction between HPV and host immune cells is crucial for cancer development insights.

Purpose:

  • To investigate the impact of overexpressing full-length HPV18 E2, and its N-terminal (TAD) and C-terminal (DBD) domains on macrophage apoptosis and cytokine secretion.
  • To elucidate the contribution of the HPV18 E2 gene to uterine cervix cancer.

Summary:

  • Recombinant plasmids encoding GFP-E2, GFP-TAD, or GFP-DBD were transfected into macrophages.
  • Overexpression of GFP-E2 and GFP-TAD significantly increased TNF-alpha and IL-1alpha secretion and elevated macrophage apoptosis rates.
  • GFP-DBD overexpression did not yield similar effects, and GFP-TAD's effect on IL-1beta was less pronounced.

Impact:

  • The findings indicate that HPV18 E2 and its TAD domain can modulate macrophage immune responses, potentially contributing to the immune evasion strategies in uterine cervix cancer.
  • This research provides a foundation for exploring targeted therapies against HPV-associated malignancies.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...